It has been shown in T1DM-rats or AD mouse models that both acute and chronic intranasal insulin treatment reduces β-amyloid levels and repairs insulin signaling through the downregulation of tau kinases and alleviates cognitive deficits [70]. The gene discussed is INS; the disease is type 1 diabetes mellitus.